Quick Answer
MIMEDX GROUP, INC. reported Total Revenue of $418.63 million for the year ending 2025.
- MIMEDX GROUP, INC. showed an increase of +20.0% in Total Revenue from 2024 to 2025.
- This data is from MIMEDX GROUP, INC.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2017: $68.80 million | Q2 2017: $80.49 million | Q3 2017: $84.00 million | Q4 2017: $87.86 million | Q1 2018: $84.15 million | Q2 2018: $95.42 million | Q3 2018: $86.96 million | Q4 2018: $92.59 million | Q1 2019: $66.56 million | Q2 2019: $67.44 million | Q3 2019: $88.86 million | Q4 2019: $76.40 million | Q1 2020: $61.74 million | Q2 2020: $53.65 million | Q3 2020: $64.30 million | Q4 2020: $68.55 million | Q1 2021: $59.97 million | Q2 2021: $68.17 million | Q3 2021: $63.07 million | Q1 2022: $58.89 million | Q2 2022: $66.88 million | Q3 2022: $67.69 million | Q1 2023: $71.68 million | Q2 2023: $81.26 million | Q3 2023: $81.71 million | Q1 2024: $84.71 million | Q2 2024: $87.21 million | Q3 2024: $84.06 million | Q1 2025: $88.21 million | Q2 2025: $98.61 million | Q3 2025: $113.73 million.
- Over the full 10 years of available data (2016 to 2025), MIMEDX GROUP, INC.'s Total Revenue has grown by 88.8%.
- Historical annual values: Fiscal year 2025: $418.63 million | Fiscal year 2024: $348.88 million | Fiscal year 2023: $321.48 million | Fiscal year 2022: $267.84 million | Fiscal year 2021: $242.02 million | Fiscal year 2020: $248.23 million | Fiscal year 2019: $299.26 million | Fiscal year 2018: $359.11 million | Fiscal year 2017: $321.14 million | Fiscal year 2016: $221.71 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: